MeSH Browser

MeSH Supplementary: pidilizumab
Unique ID: C585832
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C585832
Entry Term(s): CT 011; CT-011
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: B932PAQ1BQ
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 15
Note: an anti-programmed death 1 (PD-1) antibody; in phase II clinical trials (2013)
Source: J Clin Oncol. 2013 Nov 20;31(33):4199-206.
Date of Entry: 2014/01/22
Revision Date: 2019/11/01

pidilizumab MeSH Supplementary Concept Data 2025